Birdwatch Note Rating
2023-03-15 20:59:47 UTC - HELPFUL
Rated by Participant: E1D1BBBFAB0B57F001BE9B9BE9CA24387A16C044DB7BD239C9FEF6D34736CED0
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details